Data protection Impressum

Financing

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (January 2025)

28 January 2025

Geneva-based Transmutex has been awarded USD 4.2 million from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) as part of the NEWTON program. The funding will support a project at Los Alamos to develop technologies that transform long-lived radioactive waste into shorter-lived isotopes, addressing a critical challenge in nuclear waste management.

Transmutex secures USD 4.2 million for the transmutation of nuclear waste

27 January 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

EBAMed has secured an additional EUR 1.6 million in Series A funding, bringing the total raised to EUR 16 million. This new investment, contributed by CDP Venture Capital and the European Union, supports the development of EBAMed’s groundbreaking CardioKit system for non-invasive treatment of heart arrhythmias using Proton Therapy.

Geneva medtech EBAMed completes financing round with EUR 16 million

27 January 2025

SolidWatts has raised EUR 850,000 in a pre-seed funding round led by Evercurious VC, with participation from Switzerland’s Kickfund, COREangels Climate, and prominent angel investors. The funds will accelerate the development of its clean industrial heating solutions and expand its market presence.

SolidWatts secures funds to transform traditional industrial heating

22 January 2025

Geneva-based Cerret has launched its discreet safety bracelet, merging luxury design with advanced emergency technology. Global demand is growing rapidly, with over 150 units already shipped worldwide and 400 pre-orders in progress.

Geneva’s Cerret rethinks safety with its innovative luxury bracelet

21 January 2025

Start-up Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device, Carevix™. The campaign, hosted on the Capital Cell platform, aims to reach a target of EUR 2.15 million by 15 March 2025.

Medtech Aspivix secures EUR 1.95 million in crowdfunding

20 January 2025

Lyncée Tec, a leader in Digital Holographic Microscope (DHM) technology, has been acquired by Park Systems, a South Korean nanometrology pioneer. This strategic move enhances Park Systems' optical metrology offerings and expands their capabilities in semiconductor applications.

Lyncée Tec joins forces with South Korea’s Park Systems

15 January 2025

The Métiers du Temps | Time Arts (MTTA) project, a cutting-edge watchmaking initiative in Neuchâtel, has received national recognition from the Swiss Confederation. The project, led by Microcity, has been awarded CHF 1.6 million over four years (2025-2028) by the Federal Department of Economic Affairs, Education and Research (EAER).

Neuchâtel’s MTTA recognized as a nationally significant research infrastructure

13 January 2025

nsave has secured USD 18 million in Series A funding to expand its services, offering customers from high-inflation countries access to U.S. equities, ETFs, and investment funds.

Geneva-based fintech nsave raises USD 18 million

13 January 2025

1 2 3 4 5 6 7 … 30